| 內部人士股份 | 34,186,034 shares |
內部人士情緒分數
「內部人士情緒分數」用於查找被公司內部人士購入的公司。
它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。
更新頻率：每日
高管情緒分數
「高管情緒分數」用於查找被公司管理層購入的公司。
根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。
如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。
更新頻率：每日
關鍵內部人士指標
此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。
舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。
內部人士買入淨數（排名）
N/A
內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。
內部人士買入佔流通股比例（排名）
N/A
內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。
內幕交易圖表
以下圖表顯示了Skye Bioscience Inc內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。
內部人員名單及盈利指標
這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。
See our leaderboard of most profitable insider traders.
| 內部人士 | 平均收益（%） | 持股 數量 |
分拆 調整 |
|---|
Report errors via our new Insider Auditing Tool
追蹤內部人士買入記錄 - 短期收益分析
在這一部分，我們分析了在 EMBI / Skye Bioscience Inc 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
追蹤內部人士賣出記錄 - 短期虧損分析
在這一部分，我們分析了在 EMBI / Skye Bioscience Inc 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況， 結果僅為理論值。 .
以下表格顯示了最近的自動交易計劃之外的公開市場購買。
經調整價格 已按拆股調整。 經調整股數 已按拆股調整。
交易歷史
點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。
| 呈報 日期 |
交易 日期 |
表格 | 內部人士 | 證券代碼 | 證券種類 | 代碼 | 直接 | 行使 價格 |
單位 價格 |
股數 變化 |
價值 變化 (1K) |
剩餘 期權 |
剩餘 股份 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | 3/A | Diep Tuan Tu | SKYE | Common Stock | D | 72,833 | ||||||||
| 2026-04-02 | 3/A | Diep Tuan Tu | SKYE | Common Stock | D | 4,000 | ||||||||
| 2025-08-22 | 2025-08-22 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 3.4200 | -6,470 | -22 | 57,493 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 3.4200 | -163,979 | -561 | 1,457,064 | ||||
| 2025-08-22 | 2025-08-21 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 3.5700 | -2,314 | -8 | 63,963 | ||||
| 2025-08-22 | 2025-08-21 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 3.5700 | -58,642 | -209 | 1,621,043 | ||||
| 2025-08-22 | 2025-08-22 | 4 | 5AM Partners VII, LLC By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 3.4200 | -6,470 | -22 | 57,493 | ||||
| 2025-08-22 | 2025-08-22 | 4 | 5AM Partners VII, LLC By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 3.4200 | -163,979 | -561 | 1,457,064 | ||||
| 2025-08-22 | 2025-08-21 | 4 | 5AM Partners VII, LLC By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 3.5700 | -2,314 | -8 | 63,963 | ||||
| 2025-08-22 | 2025-08-21 | 4 | 5AM Partners VII, LLC By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 3.5700 | -58,642 | -209 | 1,621,043 | ||||
| 2025-04-25 | 3 | Twitty Christopher | SKYE | Common Stock | D | 81,242 | ||||||||
| 2025-02-28 | 2024-11-18 | 4/A | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 4.9900 | -43,026 | -215 | 167,522 | ||||
| 2025-02-28 | 2024-11-15 | 4/A | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 5.5500 | -190 | -1 | 210,548 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Diep Tuan Tu | SKYE | Common Stock | D | 4.9900 | -19,489 | -97 | 82,259 | ||||
| 2024-11-20 | 2024-11-15 | 4 | Diep Tuan Tu | SKYE | Common Stock | D | 5.5500 | -85 | -0 | 101,748 | ||||
| 2024-11-19 | 2024-11-18 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 4.9900 | -43,206 | -216 | 166,342 | ||||
| 2024-11-19 | 2024-11-15 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 5.5500 | -190 | -1 | 209,548 | ||||
| 2024-11-19 | 2024-11-18 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 4.9900 | -82,546 | -412 | 329,823 | ||||
| 2024-11-19 | 2024-11-15 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 5.5500 | -364 | -2 | 412,369 | ||||
| 2024-11-19 | 2024-11-18 | 4 | Grayson Paul A. | SKYE | Common Stock | D | 4.9900 | -86,244 | -430 | 259,701 | ||||
| 2024-11-19 | 2024-11-15 | 4 | Grayson Paul A. | SKYE | Common Stock | D | 5.5500 | -307 | -2 | 345,945 | ||||
| 2024-09-13 | 2024-09-13 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 6.0600 | -79 | -0 | 66,277 | ||||
| 2024-09-13 | 2024-09-13 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 6.0600 | -2,000 | -12 | 1,679,685 | ||||
| 2024-09-13 | 2024-09-13 | 4 | Schwab Andrew J. By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 6.0600 | -11,758 | -71 | 8,167,206 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 6.6000 | -1,440 | -10 | 66,356 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 6.6000 | -36,504 | -241 | 1,681,685 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Schwab Andrew J. By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 6.6000 | -214,556 | -1,416 | 8,178,964 | ||||
| 2024-09-13 | 2024-09-13 | 4 | 5AM Partners VII, LLC By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 6.0600 | -79 | -0 | 66,277 | ||||
| 2024-09-13 | 2024-09-13 | 4 | 5AM Partners VII, LLC By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 6.0600 | -2,000 | -12 | 1,679,685 | ||||
| 2024-09-13 | 2024-09-13 | 4 | 5AM Partners VII, LLC By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 6.0600 | -11,758 | -71 | 8,167,206 | ||||
| 2024-09-13 | 2024-09-11 | 4 | 5AM Partners VII, LLC By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 6.6000 | -1,440 | -10 | 66,356 | ||||
| 2024-09-13 | 2024-09-11 | 4 | 5AM Partners VII, LLC By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 6.6000 | -36,504 | -241 | 1,681,685 | ||||
| 2024-09-13 | 2024-09-11 | 4 | 5AM Partners VII, LLC By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 6.6000 | -214,556 | -1,416 | 8,178,964 | ||||
| 2024-08-27 | 2024-08-26 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 15,727 | 412,733 | ||||||
| 2024-03-15 | 2024-03-13 | 4 | Schwab Andrew J. By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 10.0000 | 450,000 | 4,500 | 8,393,520 | ||||
| 2024-03-15 | 2024-03-13 | 4 | 5AM Partners VII, LLC By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 10.0000 | 450,000 | 4,500 | 8,393,520 | ||||
| 2024-03-04 | 2024-02-29 | 4 | Grayson Paul A. | SKYE | Common Stock | D | 100,000 | 346,252 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Diep Tuan Tu | SKYE | Common Stock | D | 25,000 | 101,833 | ||||||
| 2024-03-04 | 2024-02-29 | 4/A | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 25,000 | 209,738 | ||||||
| 2024-03-04 | 2024-02-29 | 4/A | DHILLON PUNIT | SKYE | Common Stock | D | 100,000 | 397,006 | ||||||
| 2024-03-01 | 2024-02-29 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 25,000 | 210,738 | ||||||
| 2024-03-01 | 2024-02-29 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 100,000 | 397,006 | ||||||
| 2024-02-02 | 2024-01-31 | 4 | Schwab Andrew J. By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 2.3100 | 5,206,074 | 12,026 | 7,943,520 | ||||
| 2024-02-02 | 2024-01-31 | 4 | 5AM Partners VII, LLC By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 2.3100 | 5,206,074 | 12,026 | 7,943,520 | ||||
| 2023-11-06 | 2023-11-06 | 4 | Grayson Paul A. | SKYE | Common Stock | D | 173,721 | 246,252 | ||||||
| 2023-11-06 | 2023-11-06 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 194,270 | 297,006 | ||||||
| 2023-11-06 | 2023-11-06 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 128,209 | 185,738 | ||||||
| 2023-08-31 | 2023-08-29 | 4/A | DHILLON PUNIT | SKYE | Common Stock | D | 0.0187 | 881,000 | 16 | 25,683,957 | ||||
| 2023-08-31 | 2023-08-28 | 4/A | DHILLON PUNIT | SKYE | Common Stock | D | 0.0171 | 110,000 | 2 | 24,802,957 | ||||
| 2023-08-31 | 2023-08-25 | 4/A | DHILLON PUNIT | SKYE | Common Stock | D | 20,277,414 | 24,683,957 | ||||||
| 2023-08-31 | 2023-08-23 | 4/A | DHILLON PUNIT | SKYE | Common Stock | D | 0.0118 | 9,000 | 0 | 24,692,957 | ||||
| 2023-08-29 | 2023-08-29 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 0.0187 | 881,000 | 16 | 41,554,828 | ||||
| 2023-08-29 | 2023-08-28 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 0.0171 | 110,000 | 2 | 40,673,828 | ||||
| 2023-08-29 | 2023-08-25 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 20,277,414 | 40,554,828 | ||||||
| 2023-08-29 | 2023-08-23 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 0.0118 | 9,000 | 0 | 40,563,828 | ||||
| 2023-08-29 | 2023-08-25 | 4 | Grayson Paul A. | SKYE | Common Stock | D | 18,132,596 | 18,132,596 | ||||||
| 2023-08-29 | 2023-08-25 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 13,382,118 | 14,382,118 | ||||||
| 2023-08-28 | 3 | 5AM Partners VII, LLC By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 16,948,799 | ||||||||
| 2023-08-28 | 3 | 5AM Partners VII, LLC By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 429,546,911 | ||||||||
| 2023-08-28 | 3 | 5AM Partners VII, LLC By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 684,361,447 | ||||||||
| 2023-08-28 | 3 | Versant Ventures III, LLC By Versant Venture Capital III, L.P. | SKYE | Common Stock | I | 498,978,878 | ||||||||
| 2023-08-28 | 3 | Versant Ventures III, LLC By Versant Side Fund III, L.P. | SKYE | Common Stock | I | 2,946,924 | ||||||||
| 2023-08-22 | 2023-08-18 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 0.0103 | 6,389,921 | 66 | 16,948,799 | ||||
| 2023-08-22 | 2023-08-18 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 0.0103 | 161,944,872 | 1,668 | 429,546,911 | ||||
| 2023-08-22 | 2023-08-18 | 4 | Schwab Andrew J. By 5AM Ventures VII, L.P. | SKYE | Common Stock | I | 0.0103 | 684,361,447 | 7,049 | 684,361,447 | ||||
| 2023-08-22 | 2023-08-18 | 4 | Schwab Andrew J. By 5AM Co-Investors II, L.P. | SKYE | Common Stock | I | 10,558,878 | 10,558,878 | ||||||
| 2023-08-22 | 2023-08-18 | 4 | Schwab Andrew J. By 5AM Ventures II, L.P. | SKYE | Common Stock | I | 267,602,039 | 267,602,039 | ||||||
| 2023-03-17 | 2023-02-22 | 4 | Emerald Health Sciences Inc. | SKYE | Common Stock | D | 0.0386 | 41,379,164 | 1,597 | 169,407,901 | ||||
| 2023-03-17 | 2023-02-22 | 4 | Emerald Health Sciences Inc. | SKYE | Common Stock | D | 0.0170 | 16,641,486 | 283 | 128,028,737 | ||||
| 2022-11-15 | 2022-11-10 | 4 | DHILLON PUNIT Trust | SKYE | Common Stock | I | 2,335,721 | 2,335,721 | ||||||
| 2022-11-15 | 2022-11-10 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 1,406,543 | 4,406,543 | ||||||
| 2022-11-15 | 2022-11-10 | 4 | Rai Sukhwinder Singh Shares held by wife of Reporting Person | SKYE | Common Stock | I | 73,561 | 73,561 | ||||||
| 2022-11-15 | 2022-11-10 | 4 | Rai Sukhwinder Singh Trust | SKYE | Common Stock | I | 22,157 | 22,157 | ||||||
| 2022-01-31 | 2020-08-07 | 5 | Emerald Health Sciences Inc. | SKYE | Common Stock | D | 0.1000 | -2,566,666 | -257 | 111,387,251 | ||||
| 2022-01-31 | 2019-03-29 | 5 | Emerald Health Sciences Inc. | SKYE | Multi Draw Credit Facility - T3 | D | 0.40 | 5,354,861 | 5,354,861 | |||||
| 2022-01-31 | 2019-03-29 | 5 | Emerald Health Sciences Inc. | SKYE | Warrants with Credit Facility of Oct 5, 2018 | D | 0.50 | 2,500,000 | 2,500,000 | |||||
| 2022-01-31 | 2019-02-01 | 5 | Emerald Health Sciences Inc. | SKYE | Multi Draw Credit Facility - T2 | D | 0.40 | 38,822 | 38,822 | |||||
| 2022-01-31 | 2019-02-01 | 5 | Emerald Health Sciences Inc. | SKYE | Warrants with Credit Facility of Oct 5, 2018 | D | 0.50 | 2,500,000 | 2,500,000 | |||||
| 2022-01-31 | 2018-11-01 | 5 | Emerald Health Sciences Inc. | SKYE | Warrants with Credit Facility of Oct 5, 2018 | D | 0.50 | 2,500,000 | 2,500,000 | |||||
| 2021-12-16 | 2021-12-14 | 4 | DHILLON PUNIT | SKYE | Stock Option (Right to Buy) | D | 0.06 | 3,090,000 | 3,090,000 | |||||
| 2021-12-16 | 2021-12-14 | 4 | DHILLON PUNIT | SKYE | Common Stock | D | 2,000,000 | 3,000,000 | ||||||
| 2021-12-16 | 2021-12-14 | 4 | Arsenault Kaitlyn Melanie | SKYE | Stock Option (Right to Buy) | D | 0.06 | 1,770,000 | 1,770,000 | |||||
| 2021-12-16 | 2021-12-14 | 4 | Arsenault Kaitlyn Melanie | SKYE | Common Stock | D | 1,000,000 | 1,000,000 | ||||||
| 2021-12-16 | 2021-12-14 | 4 | Ward Keith Wayne | SKYE | Director Option Grant (Right to Buy) | D | 0.06 | 250,000 | 250,000 | |||||
| 2021-10-05 | 2021-10-04 | 4 | Arsenault Kaitlyn Melanie | SKYE | Employee Stock Option (Right to Buy) | D | 0.09 | 1,600,000 | 2,000,000 | |||||
| 2021-09-16 | 2021-09-14 | 4 | DALESANDRO MARGARET | SKYE | Director Stock Option (Right to Buy) | D | 0.12 | 150,000 | 400,000 | |||||
| 2021-09-16 | 2021-09-14 | 4 | HEPPELL JAMES L | SKYE | Director Stock Option (Right to Buy) | D | 0.12 | 150,000 | 1,350,000 | |||||
| 2021-09-16 | 2021-09-14 | 4 | TYLE PRAVEEN | SKYE | Director Stock Option (Right to Buy) | D | 0.12 | 25,000 | 275,000 | |||||
| 2021-07-26 | 2021-07-22 | 4 | TYLE PRAVEEN | SKYE | Director Option Grant (Right to Buy) | D | 0.14 | 250,000 | 250,000 | |||||
| 2020-08-13 | 2020-08-07 | 4/A | Emerald Health Sciences Inc. | EMBI | Common Stock | D | 0.1000 | -2,566,666 | -257 | 123,923,501 | ||||
| 2020-08-12 | 2020-08-07 | 4 | DALESANDRO MARGARET | EMBI | Director Option Grant (Right to Buy) | D | 0.04 | 250,000 | 250,000 | |||||
| 2020-08-11 | 2020-08-07 | 4 | Emerald Health Sciences Inc. | EMBI | Common Stock | D | 0.1000 | -3,000,000 | -300 | 123,490,167 | ||||
| 2020-08-11 | 2020-08-07 | 4 | Traistaru Elena | EMBI | Consultant Option Grant (Right to Buy) | D | 0.04 | 1,000,000 | 1,000,000 | |||||
| 2020-08-11 | 2020-08-07 | 4 | KIM DENNIS D | EMBI | Employee Stock Option (Right to Buy) | D | 0.04 | 4,000,000 | 4,736,541 | |||||
| 2020-08-11 | 2020-08-07 | 4 | HEPPELL JAMES L | EMBI | Director Option Grant (Right to Buy) | D | 0.04 | 1,000,000 | 1,200,000 | |||||
| 2020-08-11 | 2020-08-07 | 4 | HEPPELL JAMES L | EMBI | Common Stock | D | 0.1000 | 500,000 | 50 | 500,000 | ||||
| 2020-08-11 | 2020-08-07 | 4 | DHILLON PUNIT | EMBI | Employee Option Grant (Right to Buy) | D | 0.04 | 9,000,000 | 9,200,000 | |||||
| 2020-08-11 | 2020-08-07 | 4 | DHILLON PUNIT | EMBI | Common Stock | D | 0.1000 | 1,000,000 | 100 | 1,000,000 | ||||
| 2020-01-28 | 2019-12-20 | 4 | Emerald Health Sciences Inc. | EMBI | 7% Convertible Debt | D | 0.40 | 0.4000 | -4,080,000 | -1,632 | 5,036,250 | |||
| 2020-01-28 | 2019-12-20 | 4 | Emerald Health Sciences Inc. | EMBI | Warrant(Right to Buy) | D | 0.10 | 0.1000 | -40,800,000 | -4,080 | 0 | |||
| 2020-01-28 | 2019-12-20 | 4 | Emerald Health Sciences Inc. | EMBI | Common Stock | D | 4,080,000.0000 | 40,800,000 | 166,464,000,000 | 126,490,167 | ||||
| 2020-01-28 | 2019-12-20 | 4 | Emerald Health Sciences Inc. | EMBI | Common Stock | D | 0.1000 | 40,800,000 | 4,080 | 126,490,167 | ||||
| 2019-08-23 | 2019-08-21 | 4 | KIM DENNIS D | EMBI | Employee Stock Options (Right to Buy) | D | 0.30 | 736,541 | 736,541 | |||||
| 2019-04-01 | 2019-03-29 | 4 | Emerald Health Sciences Inc. | EMBI | Warrant (Right to Buy) | D | 0.50 | 2,500,000 | 7,500,000 | |||||
| 2019-04-01 | 2019-03-29 | 4 | Emerald Health Sciences Inc. | EMBI | 7% Convertible Debt | D | 0.40 | 2,000,000.0000 | 2,000,000 | 4,000,000,000 | 6,000,000 | |||
| 2019-02-01 | 2019-02-01 | 4 | Emerald Health Sciences Inc. | NMUS | Warrant (Right to Buy) | D | 0.50 | 2,500,000 | 2,500,000 | |||||
| 2019-02-01 | 2019-02-01 | 4 | Emerald Health Sciences Inc. | NMUS | 7% Convertible Debt | D | 0.40 | 2,500,000 | ||||||
| 2018-12-28 | 2018-12-27 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 37,667 | 73,153,917 | ||||||
| 2018-11-01 | 2018-11-01 | 4 | Emerald Health Sciences Inc. | NMUS | Warrant (Right to Buy) | D | 0.50 | 2,500,000 | 2,500,000 | |||||
| 2018-11-01 | 2018-11-01 | 4 | Emerald Health Sciences Inc. | NMUS | 7% Convertible Debt | D | 0.40 | 2,500,000 | ||||||
| 2018-10-12 | 2018-10-10 | 4 | DHILLON AVTAR S | NMUS | Director Stock Option (Right to Buy) | D | 0.30 | 1,000,000 | 1,000,000 | |||||
| 2018-10-12 | 3 | DHILLON AVTAR S | NMUS | No securities are beneficially owned. | D | 0 | ||||||||
| 2018-10-12 | 2018-10-10 | 4 | DHILLON PUNIT | NMUS | Director Stock Option (Right to Buy) | D | 0.30 | 200,000 | 200,000 | |||||
| 2018-10-12 | 2018-10-10 | 4 | HEPPELL JAMES L | NMUS | Director Stock Option (Right to Buy) | D | 0.30 | 200,000 | 200,000 | |||||
| 2018-07-23 | 2018-07-23 | 4 | Cesario Douglas A | NMUS | Employee Stock Option (Right to Buy) | D | 0.24 | 1,195,073 | 1,195,073 | |||||
| 2018-07-23 | 2018-07-23 | 4 | Cesario Douglas A | NMUS | Common Stock | D | 643,501 | 643,501 | ||||||
| 2018-05-31 | 3 | Cesario Douglas A | NMUS | No securities beneficially owned. | D | 0 | ||||||||
| 2018-04-03 | 2018-03-29 | 4 | Emerald Health Sciences Inc. | NMUS | Series F Convertible Preferred Stock | D | 0.10 | -2,000 | 0 | |||||
| 2018-04-03 | 2018-03-29 | 4 | Emerald Health Sciences Inc. | NMUS | Series B Convertible Preferred Stock | D | 0.10 | -1,234 | 0 | |||||
| 2018-04-03 | 2018-03-29 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 0.1000 | 20,000,000 | 2,000 | 73,116,250 | ||||
| 2018-04-03 | 2018-03-29 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 0.1000 | 12,335,000 | 1,234 | 53,116,250 | ||||
| 2018-03-02 | 2018-01-24 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock Warrant (Right to Buy) | D | 0.00 | -1,781,250 | 0 | |||||
| 2018-03-02 | 2018-01-24 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 0.0010 | 1,781,250 | 2 | 40,781,250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock Warrants (right to buy) | D | 0.10 | 20,400,000 | 20,400,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 15,000,000 | 39,000,000 | ||||||
| 2018-01-29 | 3 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 48,000,000 | ||||||||
| 2018-01-29 | 3 | Emerald Health Sciences Inc. | NMUS | Common Stock | D | 48,000,000 | ||||||||
| 2018-01-23 | 3 | DHILLON PUNIT | NMUS | No securities beneficially owned. | D | 0 | ||||||||
| 2018-01-23 | 3 | HEPPELL JAMES L | NMUS | No securities beneficially owned. | D | 0 | ||||||||
| 2018-01-22 | 2018-01-18 | 4 | Berecz Elizabeth | NMUS | Common Stock | D | 700,000 | 1,050,000 | ||||||
| 2018-01-22 | 2018-01-18 | 4 | LYKOS COSMAS N | NMUS | Common Stock | D | 900,000 | 4,599,400 | ||||||
| 2018-01-22 | 2018-01-18 | 4 | Murphy Brian Stuart | NMUS | Common Stock | D | 900,000 | 1,275,000 | ||||||
| 2017-03-28 | 2017-03-13 | 4 | Lapham Reg Alexander | NMUS | Common Stock | D | 1.0000 | -119,700 | -120 | 3,787,500 | ||||
| 2015-10-22 | 2015-10-20 | 4 | Berecz Elizabeth | NMUS | Common Stock | D | 350,000 | 350,000 | ||||||
| 2015-10-22 | 2015-10-20 | 4 | Murphy Brian Stuart | NMUS | Common Stock | D | 375,000 | 375,000 | ||||||
| 2015-10-22 | 2015-10-20 | 4 | McLaughlin Gerald W. | NMUS | Common Stock | D | 30,000 | 61,250 | ||||||
| 2015-10-22 | 2015-10-20 | 4 | LYKOS COSMAS N | NMUS | Common Stock | D | 325,000 | 3,699,400 | ||||||
| 2015-10-22 | 2015-10-20 | 4 | GEORGE THOMAS | NMUS | Common Stock | D | 60,000 | 60,000 | ||||||
| 2015-10-22 | 2015-10-20 | 4 | INGRAM DOUGLAS S | NMUS | Common Stock | D | 60,000 | 372,500 | ||||||
| 2015-08-24 | 2015-08-20 | 4 | McLaughlin Gerald W. | NMUS | Series A Preferred Stock | D | -10,000 | 0 | ||||||
| 2015-08-24 | 2015-08-20 | 4 | McLaughlin Gerald W. | NMUS | Common Stock | D | 31,250 | 31,250 | ||||||
| 2015-08-24 | 2015-08-20 | 4 | INGRAM DOUGLAS S | NMUS | Series A Preferred Stock | D | -100,000 | 0 | ||||||
| 2015-08-24 | 2015-08-20 | 4 | INGRAM DOUGLAS S | NMUS | Common Stock | D | 312,500 | 312,500 | ||||||
| 2015-06-03 | 2015-06-01 | 4 | INGRAM DOUGLAS S | NMUS | Stock Option (Right to Buy) | D | 3.00 | 40,000 | 40,000 | |||||
| 2015-06-02 | 2015-05-29 | 4 | McLaughlin Gerald W. | NMUS | Common Stock Warrant (Right to Buy) | D | 5.00 | 2,000 | 2,000 | |||||
| 2015-06-02 | 2015-05-29 | 4 | McLaughlin Gerald W. | NMUS | Series A Preferred Stock | D | 2.50 | 2.5000 | 10,000 | 25 | 10,000 | |||
| 2015-04-16 | 3 | Squires Richard D. See Footnote #1 and #3 | NMUS | Common Stock | I | 1,515,000 | ||||||||
| 2015-04-16 | 3 | Squires Richard D. | NMUS | Common Stock | D | 2,985,000 | ||||||||
| 2015-04-16 | 3 | Squires Richard D. | NMUS | Common Stock | D | 2,985,000 | ||||||||
| 2015-04-16 | 3 | Squires Richard D. See Footnote #1 and #3 | NMUS | Common Stock | I | 1,515,000 | ||||||||
| 2015-04-10 | 2015-04-10 | 4 | Ladin Brian D See Footnote #1 | NMUS | Common Stock | I | 4.9290 | -11,830 | -58 | 249,098 | ||||
| 2015-04-10 | 2015-04-08 | 4 | Ladin Brian D See Footnote #1 | NMUS | Common Stock | I | 4.7900 | -15,800 | -76 | 260,928 | ||||
| 2015-04-10 | 2015-04-08 | 4 | Ladin Brian D See Footnote #1 | NMUS | Common Stock | I | 4.6910 | -23,000 | -108 | 276,728 | ||||
| 2015-01-12 | 2015-01-09 | 4 | GEORGE THOMAS | NMUS | Stock Option (Right to Buy) | D | 3.00 | 40,000 | 40,000 | |||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (4) | NMUS | Common Stock | I | 1,423,907 | ||||||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (4) | NMUS | Common Stock | I | 1,423,907 | ||||||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (3) | NMUS | Common Stock | I | 1,560,541 | ||||||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (2) | NMUS | Common Stock | I | 1,394,268 | ||||||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (3) | NMUS | Common Stock | I | 1,560,541 | ||||||||
| 2014-12-17 | 3 | Ladin Brian D See Footnote (2) | NMUS | Common Stock | I | 1,394,268 | ||||||||
| 2014-12-08 | 2014-12-04 | 4 | McLaughlin Gerald W. | NMUS | Stock Option (Right to Buy) | D | 0.42 | 20,000 | 20,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | LYKOS COSMAS N | NMUS | Stock Option (Right to Buy) | D | 0.42 | 125,000 | 125,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Hollister John B | NMUS | Stock Option (Right to Buy) | D | 0.42 | 200,000 | 200,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Hollister John B | NMUS | Stock Option (Right to Buy) | D | 0.42 | 480,000 | 480,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Berecz Elizabeth | NMUS | Stock Option (Right to Buy) | D | 0.42 | 150,000 | 150,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Berecz Elizabeth | NMUS | Stock Option (Right to Buy) | D | 0.42 | 100,000 | 100,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Murphy Brian Stuart | NMUS | Stock Option (Right to Buy) | D | 0.42 | 175,000 | 175,000 | |||||
| 2014-12-08 | 2014-12-04 | 4 | Murphy Brian Stuart | NMUS | Stock Option (Right to Buy) | D | 0.42 | 480,000 | 480,000 | |||||
| 2014-11-10 | 2014-10-31 | 4/A | MENDEZ FRANCISCO JAVIER | LGLRD | Common Stock | D | -1,180,000 | 0 | ||||||
| 2014-11-10 | 3 | Lapham Reg Alexander | LGLRD | Common Stock | D | 7,814,400 | ||||||||
| 2014-11-10 | 3 | Lapham Reg Alexander | LGLRD | Common Stock | D | 7,814,400 | ||||||||
| 2014-11-10 | 3 | LYKOS COSMAS N | LGLRD | Common Stock | D | 6,748,800 | ||||||||
| 2014-11-10 | 3 | LYKOS COSMAS N | LGLRD | Common Stock | D | 6,748,800 | ||||||||
| 2014-11-10 | 2014-10-31 | 4 | Mendez Yosbani | LGLRD | Common Stock | D | -4,251,460 | 2,440 | ||||||
| 2014-11-10 | 2014-10-31 | 4 | MENDEZ FRANCISCO JAVIER | LGLR | Common Stock | D | -500,000 | 0 | ||||||
| 2014-01-29 | 3 | Mendez Yosbani | N/A | Common Stock | D | 1,802,500 | ||||||||
| 2014-01-29 | 3 | MENDEZ FRANCISCO JAVIER | N/A | Common Stock | D | 500,000 |
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）
